BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34342796)

  • 1. Impact of posttranslational modifications in pancreatic carcinogenesis and treatments.
    Chen N; Zheng Q; Wan G; Guo F; Zeng X; Shi P
    Cancer Metastasis Rev; 2021 Sep; 40(3):739-759. PubMed ID: 34342796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.
    Pellegrino NE; Guven A; Gray K; Shah P; Kasture G; Nastke MD; Thakurta A; Gesta S; Vishnudas VK; Narain NR; Kiebish MA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications in the cellular proteome and their clinical application.
    Elguero B; Gonilski Pacin D; Cárdenas Figueroa C; Fuertes M; Arzt E
    Medicina (B Aires); 2019; 79(Spec 6/1):570-575. PubMed ID: 31864228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.
    Zhang Y; Zeng L
    Plant Commun; 2020 Jul; 1(4):100041. PubMed ID: 33367245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation.
    Gao J; Shao K; Chen X; Li Z; Liu Z; Yu Z; Aung LHH; Wang Y; Li P
    J Mol Cell Cardiol; 2020 Jan; 138():49-58. PubMed ID: 31751566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of SUMOylation and Ubiquitination in Brain Ischaemia: Critical Concepts and Clinical Implications.
    Bernstock JD; Ye DG; Estevez D; Chagoya G; Wang YC; Gessler F; Hallenbeck JM; Yang W
    Curr Issues Mol Biol; 2020; 35():127-144. PubMed ID: 31422937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.
    Chen Z; Lu W
    Int J Mol Sci; 2015 Feb; 16(3):4560-80. PubMed ID: 25734985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer.
    Yang L; Zhou W; Lin H
    Front Oncol; 2020; 10():610663. PubMed ID: 33718111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational Modifications in Spermatozoa and Effects on Male Fertility and Sperm Viability.
    Brohi RD; Huo LJ
    OMICS; 2017 May; 21(5):245-256. PubMed ID: 28481731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers.
    Wang Y; Tong M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Protein Posttranslational Modifications from Whole-Cell Extracts in Saccharomyces cerevisiae.
    Ball LG; Xiao W
    Methods Mol Biol; 2014; 1163():249-55. PubMed ID: 24841313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Modification and Autophagy Activation.
    Wang R; Wang G
    Adv Exp Med Biol; 2019; 1206():237-259. PubMed ID: 31776989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modifications: Regulators of neurodegenerative proteinopathies.
    Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P
    Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.
    Wu X; Xu M; Geng M; Chen S; Little PJ; Xu S; Weng J
    Signal Transduct Target Ther; 2023 May; 8(1):220. PubMed ID: 37244925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations.
    Holehouse AS; Naegle KM
    PLoS One; 2015; 10(12):e0144692. PubMed ID: 26659599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination and SUMOylation: protein homeostasis control over cancer.
    Dai X; Zhang T; Hua D
    Epigenomics; 2022 Jan; 14(1):43-58. PubMed ID: 34875856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational modifications in pathogenesis of PCOS.
    Wei H; Huo P; Liu S; Huang H; Zhang S
    Front Endocrinol (Lausanne); 2022; 13():1024320. PubMed ID: 36277727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Crosstalks Between Sumoylation and Phosphorylation in Normal Cellular Physiology and Human Diseases.
    Nie Q; Gong XD; Liu M; Li DW
    Curr Mol Med; 2017; 16(10):906-913. PubMed ID: 28017137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranslational modifications of lysine and evolving role in heart pathologies-recent developments.
    Stastna M; Van Eyk JE
    Proteomics; 2015 Mar; 15(5-6):1164-80. PubMed ID: 25430483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of non-canonical post-translational modifications in gastrointestinal tumors.
    Liu Y; Liu J; Peng N; Hai S; Zhang S; Zhao H; Liu W
    Cancer Cell Int; 2023 Sep; 23(1):225. PubMed ID: 37777749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.